On June 5, WuXi AppTec (02359.HK) rose 4.21% in regular trading, reaching HK$127.2 per share with trading volume of HK$188 million, rebounding sharply after multiple consecutive sessions of decline.
On the news front, international institutions have recently increased their positions in the company. JPMorgan added approximately 499,100 H-shares on June 1 at around HK$129.05 per share, totaling approximately HK$64.41 million. Additionally, Morgan Stanley raised its H-share stake from 4.59% to 5.22% as of May 29, signaling renewed confidence from global investment banks.
The company has also maintained an aggressive buyback pace, repurchasing shares daily from June 1 through June 4, spending approximately HK$155 million, HK$132 million, HK$149 million, and HK$101 million respectively, with cumulative repurchased shares reaching 8.18 million. The sustained buyback program, combined with fresh institutional inflows, appears to have provided support following sector-wide weakness earlier in the week when the Life Sciences Tools and Services sector saw broad declines.
Within the sector, WUXI BIO rose 2.59%, Pharmaron rose 4.19%, and WUXI XDC gained 1.78%, indicating a broader sector recovery.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments